Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma

References

• Kwona K, Hanb B, Parka K et al. Analysis on the current status of targeted drug delivery to tumours. J Control Release. 2012;164(2):1–18.
   PubMed Web of Science ®Google Scholar
• Kamboj S, Saini V, Bala S, et al. Vesicular drug delivery systems: a novel approach for drug targeting. Int J Drug Deliv. 2013;5(2):121–130.
   Google Scholar
• Li J, Wang Y, Tao J et al. Recent advances in targeted nanoparticles drug delivery to melamona. Nanomedicine. 2015;11:769–794.
   PubMed Web of Science ®Google Scholar
• Naves LB, Dhand C, Reddy J, et al. Nanotechnology for the treatment of melanoma skin cancer. Prog Biomater. 2017;6:13–26.
   PubMed Web of Science ®Google Scholar
• Fohona SC, Bi-Botti CY. Current status of lectin-based cancer diagnosis and therapy. AIMS Molecular Sci. 2017;4(1):1–27.
   Web of Science ®Google Scholar
• Sina A, Roy A, Annabi B. The lectin Concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKy/NF-kB- dependent pathway. J Cell Commun Signal. 2010;4:31–38.
   PubMed Web of Science ®Google Scholar
• Lei HY, Chang CP. Induction of autophagy by Concanavalin–A and its application in antitumour therapy. Autophagy. 2007;4:402–404.
   Web of Science ®Google Scholar
• Liu B, min MW, Bao JK. Induction of apoptosis by Concanavalin-A and its molecular mechanisms in cancer cells. Autophagy. 2009;5:432–4334.
   PubMed Web of Science ®Google Scholar
• Zheng SH, Jie C, Chun-yang L. Antitumour effects of Concanavalin-A and Sophora flavescens lectin in vitro and in vivo. Acta Pharmacol Sinica. 2014;35:248–256.
   PubMed Web of Science ®Google Scholar
• Fonseca JV, Bentley LB, Iyomasa MM, et al. Evaluation of protective effect of a water-in-oil microemulsion incorporating quercetin against UVB-induced damage in hairless mice skin. J Pharm Pharmaceut Sci. 2010;13(2):274–285.
   PubMed Web of Science ®Google Scholar
• Rai S, Pandey V, Rai G. Transfersomes as versatile and flexible nanovesicular carriers in skin cancer therapy: the state of the art. Drug Deliv. 2017;8:1–18.
   Google Scholar
• Avadhani KS, Manikkathi J, Tiwari M, et al. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nanotransfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Deliv. 2017;24(1):61–74.
   PubMed Web of Science ®Google Scholar
• Saraf S, Deep C. Herbal photoprotective formulations and their evaluation. Open Nat Prod J. 2009;2:71–76.
   Google Scholar
• Saraf S, Jangdey MS, Gupta A, et al. Development and optimization of Apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation. Artif Cells Nanomed Biotechnol. 2017;45(7):1452–1462.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Cui C, Wei F et al. Improved solubility and oral bioavailability of apigenin via Soluplus/pluronic F127 binary mixed micelles system. Drug Dev Ind Pharm. 2017;43(8):1276–1282.
   PubMed Web of Science ®Google Scholar
• Saraf S, Gupta A, Alexander A, et al. Advancements and avenues in nanophytomedicines for better pharmacological responses. J Nanosci Nanotechnol. 2015;15:1–10.
   PubMed Web of Science ®Google Scholar
• Yan X, Zhan Y, Shao H, et al. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action. Cell Biosci. 2017;7(50):1–16.
   PubMed Web of Science ®Google Scholar
• Sung B, Chang HY, Kim ND. Role of apigenin in cancer prevention via the induction of apoptosis and autophagy. J Cancer Prev. 2016;4:216–226.
   Google Scholar
• Zhao G, Han X, Cheng W et al. Apigenin inhibits proliferation and invasion and induces apoptosis and cell cycle arrest in human melanoma cells. Oncol Rep. 2016;37:2277–2285.
   Web of Science ®Google Scholar
• Lee YM, Lee G, Kim BM et al. Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress. Int J Oncol. 2016;48:399–408.
   PubMed Web of Science ®Google Scholar
• Angulo P, Kaushik G, Subramaniam D, et al. Natural compounds targeting major cell signalling pathways: a novel paradigm for osteosarcoma therapy. J Hematol Oncol. 2017;10(1):1–10.
   PubMed Web of Science ®Google Scholar
• Xu M, Wang S, Song YU et al. Apigenin suppresses colorectal cancer cell proliferation migration and invasion via inhibition of the Wnt/beta-catenin signaling pathway. Oncol Let. 2016;11:3075–3080.
   PubMed Web of Science ®Google Scholar
• Bilia AR, Guccione C, Manconi M, et al. Vesicles and micelles: two versatile vectors for the delivery of natural products. J Drug Deliv Sci Technol. 2016;32:241–255.
   Web of Science ®Google Scholar
• Manconi M, Cencetti C, Nacher A et al. Nanodesign of new self-assembling core-shell gellan transfersomes loading baicalin and in vivo evaluation of repair response in skin. Nanomedicine: Nanotechnol, Biol Med. 2018;14(2):569–579.
   PubMed Web of Science ®Google Scholar
• Menezes AC, Campos PM, Euleterio C et al. Development and characterization of novel 1-(1-Naphthyl) Piperazine loaded lipid vesicles for prevention of UV-induced skin inflammation. Eur J Pharm Biopharm. 2016;104:101–109.
   PubMed Web of Science ®Google Scholar
• Kotla NG, Rooney P, Pandit A, et al. Biomimetic lipid-based nanosystems for enhanced dermal delivery of drugs and bioactive agents. ACS Biomater Sci Eng. 2017;3:1262–1272.
   PubMed Web of Science ®Google Scholar
• Cevc G, Vierl U. Nanotechnology and transdermal route: a state of the art review and critical appraisal. J Control Release. 2010;141(3):277–299.
   PubMed Web of Science ®Google Scholar
• Mirpalomo S, Nacher A, Dies-sales O, et al. Inhibition of skin inflammation by baicalin ultradeformable vesicles. Int J Pharm. 2016;511(1):23–29.
   PubMed Web of Science ®Google Scholar
• Jain S, Jain P, Umamaheshwari RB, et al. Transfersomes a novel vesicular carrier for enhanced transdermal delivery: development, characterization and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013–1026.
   PubMed Web of Science ®Google Scholar
• Saraf S, Jangdey MS, Gupta A. Fabrication, in-vitro characterization and enhanced in-vivo evaluation of carbopol based nanoemulsion gel of apigenin for UV induced skin carcinoma. Drug Deliv. 2017;24(1):1026–1036.
   PubMed Web of Science ®Google Scholar
• Grantab R, Sivananthan S, Tannock IF. The penetration of anticancer drugs through tumour tissue as a function of cellular adhesion and packing density of tumour cells. Cancer Res. 2016;66:1033–1039.
   Web of Science ®Google Scholar
• Gupta A, Kaur CD, Saraf S. Formulation, characterization, and evaluation of ligand-conjugated biodegradable quercetin nanoparticles for active targeting. Artif Cells Nanomed Biotechnol. 2016;44(3):1–11.
   PubMed Web of Science ®Google Scholar
• Cevc G, Grbauer D, Schatzlein A, et al. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1998;1368:201–215.
   PubMed Web of Science ®Google Scholar
• Abdallah MH Transfersomes as a transdermal drug delivery system for enhancement the antifungal activity of Nystatin. Int J Pharm Sci. 2013;5(4):560–567.
   Google Scholar
• Damink O, Dijikstra PJ, Feijen J, et al. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials. 1996;17(8):765–773.
   PubMed Web of Science ®Google Scholar
• Jain SK, Jangdey MS. Lectin conjugated gastro-retentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori. Int J Mol Pharmaceut. 2009;6:295–304.
   PubMed Web of Science ®Google Scholar
• Khan MA, Pandit J, Sultana Y, et al. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Deliv. 2014;22:795–802.
   PubMed Web of Science ®Google Scholar
• Saraf S, Paliwal S, Saraf S. Sphingosomes a novel approach to vesicular drug delivery. Int J Cur Sci Res. 2011;1:63–68.
   Google Scholar
• Aiyalu R, Govindarjan A, Ramasamy A. Formulation and evaluation of topical herbal gel for the treatment of arthritis in animal model. Braz J Pharm Sci. 2016;52(3):493–507.
   Web of Science ®Google Scholar
• Garg T, Goyal AK, Marwah A, et al. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 2015;23(2):564–578.
   Web of Science ®Google Scholar
• Siepmann J, Peppas NA, Modelling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv. 2001;48:139–157.
   PubMed Web of Science ®Google Scholar
• Shen LN, Zhang YT, Wang Q, Feng NP. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm. 2014;460:280–288.
   PubMed Web of Science ®Google Scholar
• Das S, Das J, Paul A, et al. Efficacy of PLGA-loaded apigenin nanoparticles in Benzopyrene and ultraviolet-B induced skin cancer of mice: mitochondria mediated apoptotic signalling cascades. Food Chem Toxicol. 2013;62:670–680.
   PubMed Web of Science ®Google Scholar
• He S, Cen B, Zhang Z. A tumour-targeting cRGD-EGFR siRNA conjugate and its anti-tumour effect on glioblastoma in vitro and in vivo. Drug deliv. 2017;24(1):471–481.
   PubMed Web of Science ®Google Scholar
• Mukerje A, Vishwanatha JK. Characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 2009;29:3867–3876.
   PubMed Web of Science ®Google Scholar
• Ahad A, Mohammed A, Kohli K, et al. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine. 2012;8:237–249.
   PubMed Web of Science ®Google Scholar
• Sarwa KK, Rudrapal M, Mazumder B. Topical ethosomal capsaicin attenuates edema and nociception in arthritic rats. Drug Deliv. 2013;22:1–10.
   Web of Science ®Google Scholar